In patients with cirrhosis who underwent a TIPS procedure, there is a greater risk of mortality linked with early recurrence of overt hepatic encephalopathy. | Read More
Adjuvant transarterial chemoembolization was associated with improved outcomes in patients with hepatocellular carcinoma and microvascular invasion, but tumor size affected efficacy. | Read More
A new study showed the long-term results of and patient satisfaction with trapezius ports in breast cancer patients is associated with high overall patient satisfaction, providing a safe and feasible alternative site to chest ports. | Read More
The introduction of computer assisted targeting solutions and efficient ablation modalities helped one high-volume center achieve excellent reproducible results as well as minimize operator dependency. | Read More
Artificial intelligence (AI) is the future of clinical data management with the potential to aid in the intersection between complex data and clinical decision making. Given AIs ability to rapidly analyze big data, interventional radiologists can design more individualized staging systems by collaborating to develop large highly organized multi-institutional registries thus improving how medicine is practiced, according to a recently published article. | Read More

Spotlight

Because overall survival of patients with metastatic neuroendocrine tumors (NET) is usually longer than other types of metastatic cancers, deciding which treatment can best control the disease over a long period of time without causing long-term side effects that might affect survival or quality of life can be challenging, according to Dr Ghassan El-Haddad, Associate Member of Vascular and Interventional Radiology and Section Head of the Radionuclide Therapy Program at the Moffitt Cancer Center and Research Institute, University of South Florida.
In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.”
Ablation and stereotactic body radiation therapy are both effective treatments for patients with hepatocellular carcinoma, especially those in early stages of the disease. Siddharth A. Padia, MD explains what interventional radiologists need to know when deciding between ablation and SBRT for HCC.